News

Filter

Taiho Pharma files for approval of cancer drug TAS-102 in Japan

27-02-2013

Japanese drugmaker Taiho Pharmaceutical, a subsidiary of Otsuka (TYO: 4768) says that it submitted an…

Asia-PacificOncologyOtsukaPharmaceuticalRegulationTaiho PharmaceuticalTAS-102

Taiho to market Merck & Co’s CTLC drug vorinostat in Japan, where MSD is expelled from JPMA

17-06-2011

US drugs giant Merck & Co’s (NYSE: MRK) Japanese subsidiary has entered into an agreement with local…

Asia-PacificLicensingMarkets & MarketingMerck & CoOncologyOtsukaPharmaceuticalTaiho PharmaceuticalvorinostatZolinza

Otsuka gastric cancer drug Teysuno gets EU approval

16-03-2011

Japanese drugmaker Otsuka (4768: JP) says that its subsidiary Taiho Pharmaceutical has received approval…

EuropeOncologyOtsukaPharmaceuticalRegulationTaiho PharmaceuticalTeysuno

COMPANY SPOTLIGHT

Menarini

Back to top